Form 4: Waystar CTO Sells Shares After Option Exercise
Insider Transaction Report
Waystar Holding Corp.'s Chief Technology Officer, Christopher L. Schremser, sold 8,623 shares of common stock after exercising vested options, pursuant to a pre-arranged 10b5-1 plan.
Summary
- Christopher L. Schremser, Chief Technology Officer of Waystar Holding Corp., engaged in a pre-planned transaction on November 10, 2025.
- Schremser exercised 8,623 stock options at an exercise price of $4.14 per share.
- Immediately following the option exercise, Schremser sold 8,623 shares of common stock at a weighted average price of $36.1161 per share.
- The sales were executed in multiple transactions ranging from $35.63 to $36.50.
- These transactions were conducted under a Rule 10b5-1(c) plan adopted on December 6, 2024.
- Following these transactions, Schremser's direct beneficial ownership of common stock, including unvested RSUs, decreased from 430,994 shares to 422,371 shares.
- Schremser retains 77,617 vested stock options.
Sentiment
Score: 5
Explanation: The transaction is neutral in sentiment as it represents a pre-planned exercise and sale by an executive, which is a common practice for managing equity compensation and does not necessarily reflect a change in the executive's outlook on the company's future performance. The sale was part of a 10b5-1 plan, mitigating any negative interpretation of an insider sale.
Positives
- The transactions were executed under a Rule 10b5-1 plan, indicating a pre-scheduled sale rather than a reaction to immediate company news.
- The sale price of $36.1161 per share is significantly higher than the exercise price of $4.14, indicating a substantial gain for the officer.
Negatives
- The Chief Technology Officer reduced his direct beneficial ownership of common stock by 8,623 shares.
Future Outlook
NA
Industry Context
This Form 4 filing details an insider transaction, which is a routine disclosure for publicly traded companies. It does not provide specific industry context or trends, but rather reflects an individual executive's pre-planned equity management strategy within the healthcare technology sector.
Stakeholder Impact
- Shareholders: The sale by a CTO could be perceived negatively by some, but the 10b5-1 plan mitigates concerns about immediate insider sentiment. The overall impact on the company's valuation or strategic direction is minimal.
- Employees: No direct impact on employees is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 12/06/2024 | Date Reporting Person adopted the Rule 10b5-1(c) plan. |
| 11/10/2025 | Date of stock option exercise and subsequent sale of common stock. |
| 11/01/2027 | Expiration date of the exercised stock options. |
| 11/12/2025 | Date the Form 4 was signed. |
Recommendation
holdThe Form 4 filing details a routine, pre-planned transaction by a company executive under a Rule 10b5-1 plan. While it involves a reduction in direct share ownership, the pre-scheduled nature of the sale suggests it is for personal financial planning rather than a reflection of new negative information about Waystar Holding Corp. The executive still retains a significant number of shares and vested options. Therefore, this specific filing does not provide a strong basis for a 'buy' or 'sell' recommendation, and a 'hold' stance is appropriate as it does not alter the fundamental investment thesis for the company.
Keywords
Waystar Holding Corp., WAY, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, Chief Technology Officer, Christopher L. Schremser, 10b5-1 Plan, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.